
APAC Contraceptives Market Analysis
The Asia-Pacific Contraceptive Drugs and Devices Market is expected to register a CAGR of 6.39% during the forecast period.
APAC Contraceptives Market Trends
Oral Contraceptive Segment is Expected to Hold the Largest Market Share in the Asia-Pacific Contraceptive Market
Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across the region by companies, and thus, easily consumed by a large section of the population, regionally. These factors are expected to contribute to the growth of the market during the forecast period.

APAC Contraceptives Industry Overview
The Asia-Pacific contraceptive market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies that are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co. Inc., CooperSurgical Inc., and Allergan PLC.
APAC Contraceptives Market Leaders
-
Bayer AG
-
Pfizer Inc.
-
Merck & Co., Inc.
-
CooperSurgical, Inc.
-
Allergan PLC
- *Disclaimer: Major Players sorted in no particular order

APAC Contraceptives Industry Segmentation
In basic terms, contraceptives refer to a set of devices, methods, medications, and techniques that are used to control births. The use of contraceptive pills, hormonal IUD, copper IUD, condoms, diaphragm, injections, and cervical cap are some commonly used contraceptive methods.
By Product | By Drugs | Oral Contraceptives | |
Topical Contraceptives | |||
Contraceptive Injectable | |||
By Device | Condoms | ||
Diaphragms | |||
Cervical Caps | |||
Sponges | |||
Vaginal Rings | |||
IUD | |||
Other Devices | |||
By Gender | Male | ||
Female | |||
Geography | Asia-Pacific | China | |
Japan | |||
India | |||
Australia | |||
South korea | |||
Rest of Asia-Pacific |
By Drugs | Oral Contraceptives |
Topical Contraceptives | |
Contraceptive Injectable | |
By Device | Condoms |
Diaphragms | |
Cervical Caps | |
Sponges | |
Vaginal Rings | |
IUD | |
Other Devices |
Male |
Female |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South korea | |
Rest of Asia-Pacific |
APAC Contraceptives Market Research FAQs
What is the current Asia-Pacific Contraceptive Drugs and Devices Market size?
The Asia-Pacific Contraceptive Drugs and Devices Market is projected to register a CAGR of 6.39% during the forecast period (2025-2030)
Who are the key players in Asia-Pacific Contraceptive Drugs and Devices Market?
Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc. and Allergan PLC are the major companies operating in the Asia-Pacific Contraceptive Drugs and Devices Market.
What years does this Asia-Pacific Contraceptive Drugs and Devices Market cover?
The report covers the Asia-Pacific Contraceptive Drugs and Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Contraceptive Drugs and Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Asia-Pacific Contraceptive Drugs and Devices Industry Report
Statistics for the 2025 Asia-Pacific Contraceptive Drugs and Devices market share, size and revenue growth rate, created by Mordor Intelligence⢠Industry Reports. Asia-Pacific Contraceptive Drugs and Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.